ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 623879 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 623879; 2) Community: the network communities that were significantly associated with the response to NSC 623879; 3) Molecule: the relationships between components within communities and NSC 623879; 4) MDR: the compounds that were significantly associated with the NSC 623879.

NSC Compound Enrichment Correlation
NSC 710895 3-[(1H-Indol-3-ylethyl)amino]-2-(3-isopropoxyphenyl)-2H-pyrido[4,3-e]-1,2,4,-thiadiazine 1,1-dioxide 0.0100967765290133 0.48476911
NSC 720386 Methyl-12.alpha.-acetoxy-5.beta.cholan-24-oate-3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane 0.0100967765290133 0.21637856
NSC 721049 7Z-Plakortide H 0.0100967765290133 0.12015437
NSC 722854 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline 0.0100967765290133 0.33737199
NSC 722867 Null 0.0100967765290133 0.17007814
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0100967765290133 0.2682486
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0100967765290133 0.084218804
NSC 732178 Null 0.0100967765290133 0.080872536
NSC 740 Methotrexate 0.0100967765290133 0.25093842
NSC 740476 Null 0.0100967765290133 0.24290085
Total:155  Current:47    [First] [Prev] [Next] [Last]